Product Code: ETC6188139 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Membrane filtration technology is critical in Australia`s pharmaceutical manufacturing for applications such as sterilization, particle removal, and water purification. With increasing quality standards and environmental considerations, there is a shift towards single-use filtration systems and high-efficiency membranes that reduce contamination risk and operational costs.
The membrane filtration market in Australia`s pharmaceutical sector is advancing with the increased need for contamination-free filtration in drug production. There is a growing trend toward the use of single-use filtration systems and ultrafiltration membranes, especially in biologics manufacturing. Enhanced focus on sterility assurance and process validation is also shaping market dynamics.
The membrane filtration segment faces issues such as membrane fouling, high operational costs, and the need for frequent maintenance. Achieving optimal filtration performance while complying with strict sterility and purity standards is challenging. Moreover, there is limited availability of specialized membranes designed for pharmaceutical applications within the domestic market.
Australia supports innovation in bioprocessing and filtration through partnerships like MTPConnect and the Cooperative Research Centres (CRC) program. Investments in this niche sector are eligible for grants under the National Reconstruction Fund when aligned with sovereign capability goals. However, technologies sourced or co-developed with foreign entities must pass FIRB scrutiny, especially where IP transfer is involved.
Membrane filtration technologies used in pharmaceutical processing are subject to stringent quality control regulations from the TGA. Policies support the adoption of validated filtration systems in line with GMP standards, ensuring sterile production environments. The Australia government also encourages the use of advanced filtration methods through tax incentives for research and development under the Research and Development Tax Incentive (RDTI) scheme.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pharmaceutical Membrane Filtration Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pharmaceutical Membrane Filtration Market - Industry Life Cycle |
3.4 Australia Pharmaceutical Membrane Filtration Market - Porter's Five Forces |
3.5 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.7 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 Australia Pharmaceutical Membrane Filtration Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Pharmaceutical Membrane Filtration Market Trends |
6 Australia Pharmaceutical Membrane Filtration Market, By Types |
6.1 Australia Pharmaceutical Membrane Filtration Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Membrane Filters, 2021- 2031F |
6.1.4 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Polyethersulfone (PES) Membrane Filters, 2021- 2031F |
6.1.5 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Polyvinylidene difluoride (PVDF) Membrane Filters, 2021- 2031F |
6.1.6 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Nylon Membrane Filters, 2021- 2031F |
6.1.7 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Polytetrafluoroethylene (PTFE), 2021- 2031F |
6.1.8 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Membrane Filters, 2021- 2031F |
6.1.9 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Other Products, 2021- 2031F |
6.1.10 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Other Products, 2021- 2031F |
6.2 Australia Pharmaceutical Membrane Filtration Market, By Technique |
6.2.1 Overview and Analysis |
6.2.2 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Microfiltration, 2021- 2031F |
6.2.3 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Ultrafiltration, 2021- 2031F |
6.2.4 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Nanofiltration, 2021- 2031F |
6.2.5 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Other Techniques, 2021- 2031F |
6.3 Australia Pharmaceutical Membrane Filtration Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Final Product processing, 2021- 2031F |
6.3.3 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Active Pharmaceutical Ingredients (APIs) Filtration, 2021- 2031F |
6.3.4 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Protein Purification, 2021- 2031F |
6.3.5 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Vaccines and Antibody Processing, 2021- 2031F |
6.3.6 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Formulation and Filling Solutions, 2021- 2031F |
6.3.7 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Viral Clearance, 2021- 2031F |
6.4 Australia Pharmaceutical Membrane Filtration Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Sterile Filtration, 2021- 2031F |
6.4.3 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Non-Sterile Filtration, 2021- 2031F |
6.4.4 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By By Scale of Operation, 2021- 2031F |
6.4.5 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Manufacturing-Scale Operation, 2021- 2031F |
6.4.6 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By Pilot-Scale Operation, 2021- 2031F |
6.4.7 Australia Pharmaceutical Membrane Filtration Market Revenues & Volume, By R&D-Scale Operation, 2021- 2031F |
7 Australia Pharmaceutical Membrane Filtration Market Import-Export Trade Statistics |
7.1 Australia Pharmaceutical Membrane Filtration Market Export to Major Countries |
7.2 Australia Pharmaceutical Membrane Filtration Market Imports from Major Countries |
8 Australia Pharmaceutical Membrane Filtration Market Key Performance Indicators |
9 Australia Pharmaceutical Membrane Filtration Market - Opportunity Assessment |
9.1 Australia Pharmaceutical Membrane Filtration Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Pharmaceutical Membrane Filtration Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.3 Australia Pharmaceutical Membrane Filtration Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Australia Pharmaceutical Membrane Filtration Market Opportunity Assessment, By Type, 2021 & 2031F |
10 Australia Pharmaceutical Membrane Filtration Market - Competitive Landscape |
10.1 Australia Pharmaceutical Membrane Filtration Market Revenue Share, By Companies, 2024 |
10.2 Australia Pharmaceutical Membrane Filtration Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |